Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 670-676

  Trombino, Concetta ^a   Tazi, Khalid A ^a   Gadano, Adrián ^a   Moreau, Richard ^a   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Calcium ionophore; Intracellular calcium; Phorbol ester; Portal hypertension; Rats; Vascular reactivity

Indexed keywords

CALCIUM ION; CALCIUM IONOPHORE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0031961442     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80292-4     Document Type: Article

References (34)

1. Mahl TC, Groszmann RJ. The pathophysiology of portal hypertension. Okuda K, Benhamou JP. Portal Hypertension: Clinical and Physiological Aspects. 1991;27-35 Springer-Verlag, Tokyo.
2. Rodés J. The evolution of knowledge on the pathophysiology of portal hypertension. De Franchis R. Portal Hypertension II: Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methology and Therapeutic Strategies. 1996;18-29 Blackwell Science, Oxford.
3. Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol. 22:1995;370-376.
4. Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol. 267:1994;C659-C678. (Cell Physiol 36).
5. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB. 1:1987;117-185.
6. Hartzell HC, Rinderknecht A, Calphostin C. A widely used protein kinase C inhibitor, directly and potently blocks L-type Ca channels. Am J Physiol. 270:1996;C1293-C1299. (Cell Physiol 39).
7. + channel of cultured porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun. 190:1993;263-269.
8. Andrea JE, Walsh MP. Protein kinase C of smooth muscle. Hypertension. 20:1992;585-595.
9. Spinozzi F, Bertotto A, Rondoni F, Gerli R, Scalise F, Grignani R. T-lymphocyte activation pathways in alcoholic liver disease. Immunology. 73:1991;140-146.
10. Wu ZY, Benoit JN. Nonreceptor-mediated intestinal vasoconstriction in portal hypertensive rats. Am J Physiol. 267:1994;H370-H375. (Heart Circ Physiol 36).
11. Tazi KA, Moreau R, Cailmail S, Gadano A, Trombino C, Lebrec D. Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats. Gastroenterology. 112:1997;2065-2072.
12. Atucha NM, Ortiz MC, Martinez C, Quesada T, Garcia-Estan J. Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension. Br J Pharmacol. 118:1996;277-282.
13. Huang YT, Wang GF, Yang MCM, Chang SP, Lin HC, Hong CY. Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement. J Pharmacol Exp Ther. 278:1996;535-541.
14. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res. 78:1996;806-812.
15. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol. 251:1986;G176-G180. (Gastrointest Liver Physiol 14).
16. Rapoport RM, Campbell AK, Bazan E. Effects of PKC downregulation on norepinephrine- and prostaglandin F 2a-induced contraction in rat aorta. Am J Physiol. 269:1995;H590-H598. (Heart Circ Physiol 38).
17. Danthuluri NR, Deth RC. Phorbol ester-induced contraction of arterial smooth muscle and inhibition of α-adrenergic response. Biochem Biophys Res Comm. 125:1984;1103-1109.
18. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension. 25:1995;415-420.
19. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, et al. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem. 266:1991;1265-1268.
20. Louis JL, Magal E, Yavin E. Protein kinase C alterations in the fetal rat brain after global ischemia. J Biol Chem. 263:1988;19282-19285.
21. Matsumoto H, Sasaki Y. Staurosprine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Comm. 158:1989;105-109.
22. Bilder GE, Kasiewski J, Perrone MH. Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of reponse in genetic hypertension. J Pharmacol Exp Ther. 252:1996;526-530.
23. Jeremy JY, Mikhailidis DP, Karatapanis S, Harry D, Burroughs AK, McIntyre N, et al. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: evidence for effects on protein kinase C and calcium. J Hepatol. 21:1994;1017-1022.
24. Laric L, Pinelli E, Carrera G, Vinel JP, Beraud M, Duffaut M, et al. Involvement of calcium in macrophage leukotriene release during experimental cirrhosis. Hepatology. 23:1996;614-622.
25. Hartleb M, Moreau R, Gaudin C, Lebrec D. Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis. J Hepatol. 22:1995;202-207.
26. Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, et al. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology. 105:1993;148-156.
27. Gopalakrishna R, Chen ZH, Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem. 268:1993;27180-27185.
28. Lewis MJ, Henderson AH. A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur J Pharmacol. 137:1987;167-171.
29. Kirstetter P, Moreau R, Vachiery F, Gadano A, Soupison T, Pilette C, et al. Plasma concentrations of cyclic 3′,5′-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics. J Gastroenterol Hepatol. 12:1997;233-236.
30. Niederberger M, Martin PY, Ginès P, Morris K, Tsai P, Wu DL, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology. 109:1995;162-1630.
31. Lang D, Lewis MJ. Endothelium-derived relaxing factor inhibits the endothelin-1-induced increase in protein kinase C activity in rat aorta. Br J Pharmacol. 104:1991;139-144.
32. Huang YT, Lo JW, Lin HC, Tsai YT, Hong CY, Yang MCM. Change in vascular cAMP and cGMP contents in portal hypertensive rats. Pharmacology. 50:1995;86-91.
33. Rapoport RM. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphadylinositol hydrolysis in rat aorta. Circ Res. 58:1986;407-410.
34. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest. 93:1994;2691-2700.